Autoimmune-related primary hypoparathyroidism possibly induced by the administration of pembrolizumab: A case report

Hitomi Umeguchi, Hiromasa Takenoshita, Hiroshi Inoue, Yuki Kurihara, Chihiro Sakaguchi, Seiichi Yano, Nao Hasuzawa, Shohei Sakamoto, Ryuichi Sakamoto, Kenji Ashida

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)449-451
Number of pages3
JournalJournal of Oncology Practice
Volume14
Issue number7
DOIs
Publication statusPublished - Jul 1 2018

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Umeguchi, H., Takenoshita, H., Inoue, H., Kurihara, Y., Sakaguchi, C., Yano, S., ... Ashida, K. (2018). Autoimmune-related primary hypoparathyroidism possibly induced by the administration of pembrolizumab: A case report. Journal of Oncology Practice, 14(7), 449-451. https://doi.org/10.1200/JOP.18.00076